# Abacavir and Lamivudine

NDC: 42385-962
Generic name: Abacavir and Lamivudine
Labeler / Manufacturer: Laurus Labs Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220725

FDA application: ANDA216332

## Active ingredients

- ABACAVIR SULFATE: 600 mg/1
- LAMIVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42385-962"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42385-962
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d12e80eb-906c-4932-bb03-b4060ba1d31c